Cargando…
Acute myeloid leukemia following etoposide therapy for EBV-associated hemophagocytic lymphohistiocytosis: a case report and a brief review of the literature
BACKGROUND: Hemophagocytic lymphohistiocytosis (HLH) is a rare, life-threatening disorder characterized by prolonged fever, cytopenia, hepatosplenomegaly, rash, icterus, and other neurological symptoms. Successful treatment of HLH by etoposide has improved outcomes for children with HLH. However, th...
Autores principales: | Pan, Hua, Feng, Dong-ning, Song, Liang, Sun, Li-rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4967337/ https://www.ncbi.nlm.nih.gov/pubmed/27473573 http://dx.doi.org/10.1186/s12887-016-0649-z |
Ejemplares similares
-
The role of etoposide in the treatment of adult patients with hemophagocytic lymphohistiocytosis
por: Zondag, Timo C. E., et al.
Publicado: (2023) -
Etoposide in patients with rheuma-associated hemophagocytic lymphohistiocytosis / macrophage activation syndrome
por: Henter, Jan-Inge, et al.
Publicado: (2011) -
“Hemophagocytic Lymphohistiocytosis after EBV reactivation and ibrutinib treatment in relapsed/refractory Chronic Lymphocytic Leukemia”
por: Cavallari, Maurizio, et al.
Publicado: (2017) -
Hemophagocytic Lymphohistiocytosis in the Setting of Therapy-Induced Acute Myeloid Leukemia: An Autopsy Report
por: Bahmad, Hisham F., et al.
Publicado: (2022) -
Possible role of low-dose etoposide therapy for hemophagocytic lymphohistiocytosis by COVID-19
por: Takami, Akiyoshi
Publicado: (2020)